Trial Profile
Feasibility study of UFT after surgery with platinum based adjuvant chemotherapy in completely resected pathological stage II/IIIA non-small cell lung cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2013
Price :
$35
*
At a glance
- Drugs Tegafur/uracil (Primary) ; Antineoplastics
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 24 Sep 2013 Status changed from active, no longer recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 22 Feb 2012 New trial record